Plasma fibronectin and platelet aggregation in diabetes mellitus

Toyoshi Inoguchi, Fumio Umeda, Jun Watanabe, Taro Wasada, Hiroshi Ibayashi

    Research output: Contribution to journalArticle

    8 Citations (Scopus)

    Abstract

    Plasma fibronectin (FN) is a high-molecular weight glycoprotein produced by endothelial cells, fibroblasts, and other mesenchymal cells. Plasma FN levels were measured in non-insulin-dependent diabetics (NIDDM) (n = 42) and compared with age-matched control subjects (n = 20). Plasma FN levels were significantly higher in the NIDDM patients (44.2 ± 2.2 mg/dl, mean ± SE) than in the control subjects (31.2 ± 2.2 mg/dl). In addition, the rate of platelet aggregation was studied in 23 of the 42NIDDM patients. Interestingly, the plasma FN levels were significantly elevated, particularly in diabetic patients with enhanced platelet aggregation. It is suggested that elevated plasma FN may be closely related to the abnormality of platelet function in diabetics, which leads to diabetic vascular lesions.

    Original languageEnglish
    Pages (from-to)69-73
    Number of pages5
    JournalDiabetes Research and Clinical Practice
    Volume2
    Issue number2
    DOIs
    Publication statusPublished - Jan 1 1986

    Fingerprint

    Platelet Aggregation
    Fibronectins
    Diabetes Mellitus
    Type 2 Diabetes Mellitus
    Blood Vessels
    Glycoproteins
    Blood Platelets
    Endothelial Cells
    Fibroblasts
    Molecular Weight

    All Science Journal Classification (ASJC) codes

    • Endocrinology
    • Endocrinology, Diabetes and Metabolism
    • Internal Medicine

    Cite this

    Plasma fibronectin and platelet aggregation in diabetes mellitus. / Inoguchi, Toyoshi; Umeda, Fumio; Watanabe, Jun; Wasada, Taro; Ibayashi, Hiroshi.

    In: Diabetes Research and Clinical Practice, Vol. 2, No. 2, 01.01.1986, p. 69-73.

    Research output: Contribution to journalArticle

    Inoguchi, Toyoshi ; Umeda, Fumio ; Watanabe, Jun ; Wasada, Taro ; Ibayashi, Hiroshi. / Plasma fibronectin and platelet aggregation in diabetes mellitus. In: Diabetes Research and Clinical Practice. 1986 ; Vol. 2, No. 2. pp. 69-73.
    @article{8ad6cd8ffc684c6fad6f9fbddcf51c9f,
    title = "Plasma fibronectin and platelet aggregation in diabetes mellitus",
    abstract = "Plasma fibronectin (FN) is a high-molecular weight glycoprotein produced by endothelial cells, fibroblasts, and other mesenchymal cells. Plasma FN levels were measured in non-insulin-dependent diabetics (NIDDM) (n = 42) and compared with age-matched control subjects (n = 20). Plasma FN levels were significantly higher in the NIDDM patients (44.2 ± 2.2 mg/dl, mean ± SE) than in the control subjects (31.2 ± 2.2 mg/dl). In addition, the rate of platelet aggregation was studied in 23 of the 42NIDDM patients. Interestingly, the plasma FN levels were significantly elevated, particularly in diabetic patients with enhanced platelet aggregation. It is suggested that elevated plasma FN may be closely related to the abnormality of platelet function in diabetics, which leads to diabetic vascular lesions.",
    author = "Toyoshi Inoguchi and Fumio Umeda and Jun Watanabe and Taro Wasada and Hiroshi Ibayashi",
    year = "1986",
    month = "1",
    day = "1",
    doi = "10.1016/S0168-8227(86)80062-6",
    language = "English",
    volume = "2",
    pages = "69--73",
    journal = "Diabetes Research and Clinical Practice",
    issn = "0168-8227",
    publisher = "Elsevier Ireland Ltd",
    number = "2",

    }

    TY - JOUR

    T1 - Plasma fibronectin and platelet aggregation in diabetes mellitus

    AU - Inoguchi, Toyoshi

    AU - Umeda, Fumio

    AU - Watanabe, Jun

    AU - Wasada, Taro

    AU - Ibayashi, Hiroshi

    PY - 1986/1/1

    Y1 - 1986/1/1

    N2 - Plasma fibronectin (FN) is a high-molecular weight glycoprotein produced by endothelial cells, fibroblasts, and other mesenchymal cells. Plasma FN levels were measured in non-insulin-dependent diabetics (NIDDM) (n = 42) and compared with age-matched control subjects (n = 20). Plasma FN levels were significantly higher in the NIDDM patients (44.2 ± 2.2 mg/dl, mean ± SE) than in the control subjects (31.2 ± 2.2 mg/dl). In addition, the rate of platelet aggregation was studied in 23 of the 42NIDDM patients. Interestingly, the plasma FN levels were significantly elevated, particularly in diabetic patients with enhanced platelet aggregation. It is suggested that elevated plasma FN may be closely related to the abnormality of platelet function in diabetics, which leads to diabetic vascular lesions.

    AB - Plasma fibronectin (FN) is a high-molecular weight glycoprotein produced by endothelial cells, fibroblasts, and other mesenchymal cells. Plasma FN levels were measured in non-insulin-dependent diabetics (NIDDM) (n = 42) and compared with age-matched control subjects (n = 20). Plasma FN levels were significantly higher in the NIDDM patients (44.2 ± 2.2 mg/dl, mean ± SE) than in the control subjects (31.2 ± 2.2 mg/dl). In addition, the rate of platelet aggregation was studied in 23 of the 42NIDDM patients. Interestingly, the plasma FN levels were significantly elevated, particularly in diabetic patients with enhanced platelet aggregation. It is suggested that elevated plasma FN may be closely related to the abnormality of platelet function in diabetics, which leads to diabetic vascular lesions.

    UR - http://www.scopus.com/inward/record.url?scp=0022861203&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0022861203&partnerID=8YFLogxK

    U2 - 10.1016/S0168-8227(86)80062-6

    DO - 10.1016/S0168-8227(86)80062-6

    M3 - Article

    C2 - 3720501

    AN - SCOPUS:0022861203

    VL - 2

    SP - 69

    EP - 73

    JO - Diabetes Research and Clinical Practice

    JF - Diabetes Research and Clinical Practice

    SN - 0168-8227

    IS - 2

    ER -